Biotech · Private company
Salarius Pharmaceuticals, LLC
Track this companyFree. Adds Salarius Pharmaceuticals, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- SeclidemstatPhase 2 · Ewing SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 1 · Ewing SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- SP-2577 SeclidemstatPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- TopotecanPhase 1 · Ewing SarcomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)PHASE1_PHASE2 · UNKNOWN · started Jan 15, 2022ClinicalTrials.gov NCT05266196 · fetched Nov 12, 2026
- Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic CancersPHASE1 · WITHDRAWN · started Dec 31, 2021ClinicalTrials.gov NCT04611139 · fetched Nov 12, 2026
- Phase 1 Trial of the LSD1 Inhibitor SP-2577 (Seclidemstat) in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Jun 25, 2019ClinicalTrials.gov NCT03895684 · fetched Nov 12, 2026
- Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related SarcomasPHASE1 · UNKNOWN · started Jun 4, 2018ClinicalTrials.gov NCT03600649 · fetched Nov 12, 2026